secwatch / observer
8-K filed December 7, 2022, 6:59 PM ET ticker WLY CIK 0000107140
earnings confidence high sentiment negative materiality 0.80

Wiley Q2 revenue $515M (-3% YoY); lowers FY23 revenue guidance on consumer/enrollment headwinds

JOHN WILEY & SONS, INC.

2023-Q2 EPS reported $0.36 revenue$1,002,405,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

JOHN WILEY & SONS, INC. reported second quarter ended October 31, 2022 results: revenue $515 million, EPS $0.68. Guidance lowered.

Period
second quarter ended October 31, 2022
Revenue
$515 million
EPS
$0.68
Guidance
lowered
Result
reported results
Exact text from the filing
Wiley Reports Second Quarter Fiscal Year 2023 Results December 7, 2022 - Hoboken, NJ – Wiley (NYSE: WLY), one of the world's largest publishers and a global leader in scientific research and career-connected education, today announced results for the second quarter ended October 31, 2022. • GAAP Results : Revenue of $515 million (-3% vs. prior year), Operating Income of $57 million (-22% vs. prior year), and EPS of $0.68 (-31% vs. prior year) • Adjusted Results at constant currency : Revenue of $515 million (+1% vs. prior year), Adjusted EBITDA of $124 million (-4% vs. prior year), and Adjusted EPS of $1.20 (-13% vs. prior year) • Fiscal 2023 Outlook: Wiley is lowering its revenue outlook at constant currency due to consumer spending and enrollment headwinds in Academic & Professional Learning. Reaffirms full year outlook for Adjusted EBITDA and Free Cash Flow; Adjusted EPS trending to lower end of range mainly due to rising interest expense
View on SEC.gov

59 earnings releases filed in the last 30 days. Browse all earnings releases →

JOHN WILEY & SONS, INC. filing history →

Source: SEC EDGAR
accession 0000107140-22-000092
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.